Boundless Bio (BOLD) Accumulated Expenses (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Accumulated Expenses of $589000.0 for Q1 2026, down 47.55% year-over-year from $1.1 million in Q1 2025, and down 77.71% quarter-over-quarter from $2.6 million in Q4 2025.
Boundless Bio (BOLD) Accumulated Expenses (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Accumulated Expenses for 4 consecutive years, with $589000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 47.55% year-over-year to $589000.0; the TTM figure through Mar 2026 stood at $589000.0 (down 47.55% YoY), while the FY2025 annual figure was $2.6 million, down 4.96% from the prior year.
- Accumulated Expenses fell to $589000.0 in Q1 2026 per BOLD's latest filing, from $2.6 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.9 million in Q4 2023 and bottomed at $589000.0 in Q1 2026.
- Historically, Accumulated Expenses has averaged $1.9 million across 4 years, with a median of $2.0 million in 2024.
- Annual changes were most pronounced in 2025 — Accumulated Expenses gained 19.6% — and 2026, when it sank 47.55%.
- Boundless Bio's Accumulated Expenses stood at $2.9 million in 2023, then declined by 4.04% to $2.8 million in 2024, then dropped by 4.96% to $2.6 million in 2025, then tumbled by 77.71% to $589000.0 in 2026.
- Business Quant data shows BOLD's Accumulated Expenses at $589000.0 in Q1 2026, $2.6 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.77 Mn |
| Mar 31, 2026 | 589,000.00 |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 939,000.00 |
| Dec 31, 2023 | 2.90 Mn |